Skip to main content

BREAST: CB-4-23 | ELEVATE

Trial ID
NCT05563220
Trial Sponsor
Stemline Therapeutics, Inc.

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer (ELEVATE)

ANNOUNCEMENT: We no longer accept cash payments.

X

By using this website, you agree to the use of cookies and our privacy policy.

X